Emmanuel Ansong, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenium-Binding Proteins | 4 | 2015 | 18 | 1.220 |
Why?
|
| Pregnancy, Abdominal | 1 | 2019 | 6 | 0.650 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 81 | 0.630 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2019 | 64 | 0.620 |
Why?
|
| Premenstrual Syndrome | 1 | 2019 | 109 | 0.610 |
Why?
|
| Dysmenorrhea | 1 | 2019 | 98 | 0.590 |
Why?
|
| Glutathione Peroxidase | 3 | 2017 | 258 | 0.570 |
Why?
|
| Menstruation | 1 | 2019 | 307 | 0.570 |
Why?
|
| Laparotomy | 1 | 2019 | 457 | 0.540 |
Why?
|
| Selenoproteins | 2 | 2018 | 215 | 0.520 |
Why?
|
| Methotrexate | 1 | 2019 | 1719 | 0.390 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2015 | 1062 | 0.360 |
Why?
|
| Students | 1 | 2019 | 1741 | 0.320 |
Why?
|
| Laparoscopy | 1 | 2019 | 2036 | 0.280 |
Why?
|
| Magnesium Sulfate | 2 | 2017 | 73 | 0.270 |
Why?
|
| Phosphoinositide Phospholipase C | 2 | 2017 | 29 | 0.250 |
Why?
|
| Selenium | 3 | 2018 | 417 | 0.240 |
Why?
|
| Esophagitis | 2 | 2017 | 164 | 0.220 |
Why?
|
| China | 2 | 2019 | 2374 | 0.210 |
Why?
|
| HCT116 Cells | 3 | 2015 | 404 | 0.170 |
Why?
|
| Gynatresia | 1 | 2018 | 11 | 0.160 |
Why?
|
| Selenoprotein P | 1 | 2018 | 33 | 0.150 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 550 | 0.140 |
Why?
|
| Protein Kinase C-alpha | 1 | 2017 | 113 | 0.140 |
Why?
|
| Sirtuin 3 | 1 | 2017 | 67 | 0.140 |
Why?
|
| Prostatic Neoplasms | 2 | 2018 | 11122 | 0.130 |
Why?
|
| Toes | 1 | 2017 | 209 | 0.130 |
Why?
|
| Endometrium | 1 | 2018 | 403 | 0.130 |
Why?
|
| Esophageal Neoplasms | 2 | 2017 | 1654 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 594 | 0.120 |
Why?
|
| Postoperative Period | 1 | 2019 | 1814 | 0.110 |
Why?
|
| Codon | 1 | 2015 | 601 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1186 | 0.110 |
Why?
|
| Universities | 1 | 2019 | 993 | 0.110 |
Why?
|
| Sciatic Nerve | 1 | 2017 | 617 | 0.110 |
Why?
|
| Diabetic Foot | 1 | 2017 | 380 | 0.110 |
Why?
|
| Cadherins | 1 | 2017 | 903 | 0.100 |
Why?
|
| Hyperalgesia | 1 | 2016 | 532 | 0.100 |
Why?
|
| Metformin | 1 | 2018 | 906 | 0.090 |
Why?
|
| Cysteine | 1 | 2015 | 891 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 1406 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2015 | 1510 | 0.090 |
Why?
|
| Ketamine | 1 | 2016 | 519 | 0.090 |
Why?
|
| Nerve Block | 1 | 2017 | 706 | 0.090 |
Why?
|
| Anesthetics, Local | 1 | 2017 | 997 | 0.090 |
Why?
|
| Regeneration | 1 | 2018 | 1512 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2457 | 0.080 |
Why?
|
| Piperidines | 1 | 2016 | 1656 | 0.070 |
Why?
|
| Colon | 1 | 2015 | 1792 | 0.070 |
Why?
|
| Prostatectomy | 1 | 2015 | 1824 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 1902 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2015 | 2910 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10451 | 0.050 |
Why?
|
| Glucose | 1 | 2015 | 4347 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 2539 | 0.050 |
Why?
|
| Apoptosis | 1 | 2018 | 9490 | 0.050 |
Why?
|
| Young Adult | 2 | 2019 | 59260 | 0.050 |
Why?
|
| Prevalence | 1 | 2019 | 15733 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8554 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 9280 | 0.040 |
Why?
|
| Adolescent | 2 | 2019 | 88326 | 0.040 |
Why?
|
| Prognosis | 3 | 2017 | 29629 | 0.040 |
Why?
|
| Humans | 12 | 2020 | 761596 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26129 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 15936 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 6131 | 0.040 |
Why?
|
| Anesthetics, Combined | 1 | 2017 | 43 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 4024 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 221210 | 0.040 |
Why?
|
| Pregnancy | 1 | 2019 | 29890 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 16990 | 0.030 |
Why?
|
| Female | 7 | 2019 | 392705 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2016 | 318 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 4915 | 0.030 |
Why?
|
| Amides | 1 | 2017 | 449 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9353 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 730 | 0.030 |
Why?
|
| Gene Expression | 2 | 2017 | 7581 | 0.030 |
Why?
|
| Mitochondria | 2 | 2017 | 3624 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 2017 | 492 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2016 | 604 | 0.030 |
Why?
|
| Plasmids | 1 | 2017 | 2269 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64685 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 74213 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 1486 | 0.020 |
Why?
|
| Fibrosis | 1 | 2018 | 2049 | 0.020 |
Why?
|
| Esophagus | 1 | 2017 | 1033 | 0.020 |
Why?
|
| Genotype | 2 | 2018 | 12990 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 789 | 0.020 |
Why?
|
| Rats | 2 | 2017 | 23741 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 11120 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2018 | 5035 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1742 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 80647 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1704 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 1646 | 0.020 |
Why?
|
| Prostate | 1 | 2018 | 1773 | 0.020 |
Why?
|
| Transfection | 1 | 2017 | 5774 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3614 | 0.020 |
Why?
|
| Male | 5 | 2018 | 360846 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8181 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 4243 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2017 | 4001 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6214 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8321 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3551 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6864 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 1740 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 2827 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 5791 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6766 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 3517 | 0.020 |
Why?
|
| Animals | 4 | 2018 | 168475 | 0.010 |
Why?
|
| Neoplasms | 1 | 2013 | 22173 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10766 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11076 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6075 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2017 | 23447 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7396 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2017 | 12794 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14417 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20100 | 0.010 |
Why?
|
| Proteomics | 1 | 2015 | 3848 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18255 | 0.010 |
Why?
|
| Mice | 2 | 2017 | 81539 | 0.010 |
Why?
|
| Middle Aged | 3 | 2018 | 220921 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39106 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17904 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22176 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 169310 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13642 | 0.010 |
Why?
|